DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,511 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,766,538 | -23.7% | 23,080 | -23.7% | 0.14% | -5.5% |
| Q1 2024 | $7,555,279 | +483.6% | 30,255 | +440.7% | 0.14% | +339.4% |
| Q4 2023 | $1,294,579 | -47.7% | 5,596 | -45.8% | 0.03% | -38.9% |
| Q2 2023 | $2,475,840 | -81.3% | 10,316 | -80.3% | 0.05% | -80.1% |
| Q1 2023 | $13,206,896 | +4238.1% | 52,400 | +4468.4% | 0.27% | +3771.4% |
| Q4 2022 | $304,437 | -65.3% | 1,147 | -66.3% | 0.01% | -68.2% |
| Q3 2022 | $878,000 | -47.5% | 3,400 | -48.4% | 0.02% | -50.0% |
| Q2 2022 | $1,672,000 | -44.6% | 6,593 | -35.9% | 0.04% | -37.1% |
| Q1 2022 | $3,016,000 | +70.1% | 10,282 | +90.8% | 0.07% | +66.7% |
| Q4 2021 | $1,773,000 | +535.5% | 5,388 | +417.6% | 0.04% | +366.7% |
| Q2 2021 | $279,000 | -50.2% | 1,041 | -60.0% | 0.01% | -73.5% |
| Q3 2020 | $560,000 | -43.8% | 2,602 | -53.8% | 0.03% | -50.0% |
| Q2 2020 | $996,000 | -12.3% | 5,633 | -31.4% | 0.07% | -27.7% |
| Q1 2020 | $1,136,000 | +97.2% | 8,206 | +118.6% | 0.09% | +88.0% |
| Q4 2019 | $576,000 | -4.5% | 3,754 | -10.0% | 0.05% | -9.1% |
| Q3 2019 | $603,000 | -24.2% | 4,172 | -25.0% | 0.06% | -23.6% |
| Q2 2019 | $795,000 | +13.2% | 5,565 | +4.6% | 0.07% | +5.9% |
| Q1 2019 | $702,000 | -23.9% | 5,321 | -40.5% | 0.07% | -49.6% |
| Q4 2018 | $923,000 | +18.2% | 8,950 | +24.5% | 0.14% | +75.3% |
| Q3 2018 | $781,000 | +88.2% | 7,191 | +71.0% | 0.08% | +113.9% |
| Q2 2018 | $415,000 | -17.0% | 4,205 | -17.7% | 0.04% | -39.0% |
| Q1 2018 | $500,000 | +30.9% | 5,110 | +12.8% | 0.06% | -25.3% |
| Q2 2017 | $382,000 | +90.0% | 4,532 | +77.0% | 0.08% | +79.5% |
| Q3 2016 | $201,000 | -43.2% | 2,561 | -26.9% | 0.04% | -67.9% |
| Q2 2016 | $354,000 | -24.0% | 3,502 | -30.3% | 0.14% | -33.5% |
| Q4 2015 | $466,000 | -16.6% | 5,022 | -23.4% | 0.21% | -22.6% |
| Q3 2015 | $559,000 | +13.6% | 6,558 | +14.1% | 0.27% | +24.3% |
| Q2 2015 | $492,000 | +99.2% | 5,746 | +97.2% | 0.21% | +31.3% |
| Q1 2015 | $247,000 | – | 2,914 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |